MGNX

$3.13+0.05 (+1.62%)

Market ClosedLast close May 1

MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics for the treatment of cancer in the United States.

Overview Intraday ResearchPRO OptionsPRO BacktestPRO Ask AIPRO TranscriptsPRO StatementsPRO